Literature DB >> 28073863

Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.

Christel Renoux1,2,3, Janie Coulombe1, Samy Suissa1,3.   

Abstract

AIMS: In patients with non-valvular atrial fibrillation (NVAF), it is uncertain whether the higher risk of ischaemic stroke in women reported in some studies is due to residual confounding. We assessed this association using standard time-fixed and more accurate time-dependent adjustment for confounders. METHODS AND
RESULTS: Using the computerized databases of the Régie de l'assurance maladie du Québec (RAMQ), we identified a cohort of patients with NVAF during 2000-2009 and RAMQ medication coverage. Cox proportional hazards models were used to estimate the hazard ratio (HR) of ischaemic stroke, death, and bleeding, associated with sex, adjusting for time-fixed covariates at cohort entry. This was compared with adjustment for time-dependent covariates using an age and time-matched nested case-control analysis. The cohort included 147 622 patients. During a mean follow-up of 2.9 years 11 326 patients had a stroke (incidence rate 2.6 per 100 per year). Using time-fixed adjustment for confounders, women had a moderately higher risk of ischaemic stroke than men (HR 1.16 (Confidence interval (CI) 95% 1.11-1.21). Matching on age and using time-dependent adjustment for confounders, women were not at higher risk of stroke than men (Rate Ratio 1.01; 95% CI 0.97-1.05). Mortality and bleeding rates were lower in women compared with men in both analyses.
CONCLUSION: In NVAF, women were not at higher risk of thromboembolic events than men in our study. The small increased risk reported in previous studies may be related to residual confounding, in particular from insufficient control for age. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation ; Epidemiology ; Mortality; Sex ; Stroke

Mesh:

Year:  2017        PMID: 28073863     DOI: 10.1093/eurheartj/ehw613

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  Female sex and stroke in atrial fibrillation: an intriguing relationship.

Authors:  Giuseppe Boriani; Jacopo Colella; Jacopo Imberti; Elisa Fantecchi; Marco Vitolo
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

2.  Sex Difference in the Risk of Dementia in Patients with Atrial Fibrillation.

Authors:  Yung-Lung Chen; Joseph Chen; Hui-Ting Wang; Ya-Ting Chang; Shaur-Zheng Chong; Shukai Hsueh; Chang-Ming Chung; Yu-Sheng Lin
Journal:  Diagnostics (Basel)       Date:  2021-04-23

3.  Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonists.

Authors:  Na He; Sophie Dell'Aniello; Suodi Zhai; Samy Suissa; Christel Renoux
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-09-21

4.  Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.

Authors:  Ethan D Borre; Adam Goode; Giselle Raitz; Bimal Shah; Angela Lowenstern; Ranee Chatterjee; Lauren Sharan; Nancy M Allen LaPointe; Roshini Yapa; J Kelly Davis; Kathryn Lallinger; Robyn Schmidt; Andrzej Kosinski; Sana M Al-Khatib; Gillian D Sanders
Journal:  Thromb Haemost       Date:  2018-10-30       Impact factor: 6.681

Review 5.  Women and atrial fibrillation.

Authors:  Annabelle Santos Volgman; Emelia J Benjamin; Anne B Curtis; Margaret C Fang; Kathryn J Lindley; Gerald V Naccarelli; Carl J Pepine; Odayme Quesada; Marmar Vaseghi; Albert L Waldo; Nanette K Wenger; Andrea M Russo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-12-29       Impact factor: 2.942

6.  Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants.

Authors:  Amélie Gabet; Edouard Chatignoux; Clémence Grave; Alexandre Vallée; Philippe Tuppin; Yannick Béjot; Valérie Olié
Journal:  Clin Epidemiol       Date:  2021-02-19       Impact factor: 4.790

7.  Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study.

Authors:  Anne Holbrook; Harsukh Benipal; J Michael Paterson; Diana Martins; Simon Greaves; Munil Lee; Tara Gomes
Journal:  CMAJ Open       Date:  2021-04-16

8.  Atrial fibrillation: risk factors and comorbidities in a tertiary center in Jeddah, Saudi Arabia.

Authors:  Abdullah Abdulfattah Mashat; Ahmed Hussein Subki; Moaz Abdulrahman Bakhaider; Wejdan Mohammad Baabdullah; Jawaher Badr Walid; Abdulrahman Hatim Alobudi; Maged Mazen Fakeeh; Anas Jamal Algethmi; Wesam Awad Alhejily
Journal:  Int J Gen Med       Date:  2019-01-11

9.  Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China-AF Study.

Authors:  Di-Hui Lan; Chao Jiang; Xin Du; Liu He; Xue-Yuan Guo; Song Zuo; Shi-Jun Xia; San-Shuai Chang; Song-Nan Wen; Jia-Hui Wu; Yan-Fei Ruan; De-Yong Long; Ri-Bo Tang; Rong-Hui Yu; Cai-Hua Sang; Rong Bai; Nian Liu; Chen-Xi Jiang; Song-Nan Li; Jian-Zeng Dong; Gregory Y H Lip; Ai-Hua Chen; Chang-Sheng Ma
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

Review 10.  Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.

Authors:  Wern Yew Ding; Stephanie Harrison; Dhiraj Gupta; Gregory Y H Lip; Deirdre A Lane
Journal:  Front Med (Lausanne)       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.